1. Home
  2. AVTX vs MPV Comparison

AVTX vs MPV Comparison

Compare AVTX & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • MPV
  • Stock Information
  • Founded
  • AVTX 2011
  • MPV 1988
  • Country
  • AVTX United States
  • MPV United States
  • Employees
  • AVTX N/A
  • MPV N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • MPV Finance Companies
  • Sector
  • AVTX Health Care
  • MPV Finance
  • Exchange
  • AVTX Nasdaq
  • MPV Nasdaq
  • Market Cap
  • AVTX 248.3M
  • MPV 201.1M
  • IPO Year
  • AVTX 2015
  • MPV N/A
  • Fundamental
  • Price
  • AVTX $18.62
  • MPV $20.22
  • Analyst Decision
  • AVTX Strong Buy
  • MPV
  • Analyst Count
  • AVTX 9
  • MPV 0
  • Target Price
  • AVTX $30.14
  • MPV N/A
  • AVG Volume (30 Days)
  • AVTX 351.6K
  • MPV 25.2K
  • Earning Date
  • AVTX 11-06-2025
  • MPV 01-01-0001
  • Dividend Yield
  • AVTX N/A
  • MPV 8.71%
  • EPS Growth
  • AVTX N/A
  • MPV N/A
  • EPS
  • AVTX N/A
  • MPV 1.71
  • Revenue
  • AVTX $192,000.00
  • MPV N/A
  • Revenue This Year
  • AVTX N/A
  • MPV N/A
  • Revenue Next Year
  • AVTX N/A
  • MPV N/A
  • P/E Ratio
  • AVTX N/A
  • MPV $9.35
  • Revenue Growth
  • AVTX N/A
  • MPV N/A
  • 52 Week Low
  • AVTX $3.39
  • MPV $11.18
  • 52 Week High
  • AVTX $19.41
  • MPV $16.42
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 64.08
  • MPV 62.18
  • Support Level
  • AVTX $16.75
  • MPV $19.51
  • Resistance Level
  • AVTX $19.29
  • MPV $20.22
  • Average True Range (ATR)
  • AVTX 1.41
  • MPV 0.33
  • MACD
  • AVTX 0.17
  • MPV 0.07
  • Stochastic Oscillator
  • AVTX 87.31
  • MPV 100.00

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About MPV Barings Participation Investors

Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.

Share on Social Networks: